In addition, immunohistochemistry of intracranial glioma tissues further confirmed that CYB561D2 increased PD-L1, MMP2 (invasion marker) and Ki-67 (proliferation marker) in a STAT3-depedendt manner (Fig. 7D). This evidence concerns the gene MMP2 and central nervous system cancer.